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Abstract of thesis presented to the Senate ofUniversiti Putra Malaysia in  fulfilment of 
the requirements for the degree of Master of Science. 
EFFECT OF BREAST CYST FLUID ON OESTRONE SULPHA TASE 
ACTIVITY IN BREAST CANCER CELL LINES 
By 
RASHA EL-HAG EL-SADIG 
September 2000 
Chairman: Professor Dr. Leslie C Lai 
Faculty: Medicine and Health Sciences 
Breast cancer is the most common cancer in women worldwide. Although breast 
cancers are general ly oestrogen receptor positive initially, a substantial proportion 
become oestrogen receptor negative. Oestrogen receptor positive breast cancers are 
associated with a better prognosis than oestrogen receptor negative breast cancers as 
they are more responsive to hormonal therapy. 
Breast cyst fluid (BCF) is known to be a rich source of steroid hormones and 
growth factors. These substances may have significant effects on mammary epithelial 
cell growth and oestrogen metabolism in the breast and may, thus, play important roles 
in the pathophysiology and development of breast cancer. Oestrone sulphate acts as a 
large reservoir of active oestrogens in the breast and is converted to oestrone by the 
enzyme oestrone sulphatase. The aims of the present study were to assess the effects of 
BCF on cell growth of, and oestrone sulphatase activity in the MCF-7 oestrogen 
III 
receptor positive and MDA-MB-23 1 oestrogen receptor negative breast cancer cel l  l ines 
and to determine the molecular weights of the proteinsipeptides in BCF responsible for 
the inhibition of oestrone sulphatase activity. 
MCF-7 and MDA-MB-23 1 cell growth were significantly inhibited by BCF. 
Oestrone sulphatase activity was significantly inhibited in the MDA-MB-23 1 cells 
while oestrone sulphatase activity was significantly stimulated in MCF-7 cell by BCF. 
Oestrone sulphatase activity was significantly inhibited by both dialysed BCF and 
dialysate. 
The presence of endogenous inhibitors of oestrone sulphatase in BCF is 
important because inhibitors of oestrone sulphatase are potential agents for the 
treatment of hormone-dependent breast cancers. The substance present in BCF, which 
corresponds to a molecular weight of around 28 kDa, may possibly have a role to play 
in the prevention of breast cancer development and progression. 
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Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia 
sebagai memenuhi keperluan untuk ijazah Master Sains. 
KESAN BENDALIR SISTA PA YUDARA KEATAS AKTIVITI ESTRON 
SULFATASE PADA TITISAN SEL BARAH PAYUDARA 
Oleh 
RASHA EL-HAG EL-SADIG 
September 2000 
Pengerusi: Professor Dr. Leslie C Lai 
Fakulti: Perubatan dan Sains Kesihatan 
Barah payudara adalah barah yang paling kerap terjadi dikalangan wanita di 
seluruh dunia. Walaupun pada peringkat awalnya barah payudara secara amnya adalah 
reseptor estrogen positif, sebahagian daripadanya akan menjadi reseptor estrogen 
negatif Reseptor estrogen positif payudara adalah berkait dengan prognosis yang lebih 
baik berbanding dengan reseptor estrogen negatif kerana ianya lebih bergerakbalas 
terhadap terapi hormon. 
Bendalir  sista payudara (BCF) diketahui kaya dengan hormon-hormon steroid dan 
faktor-faktor pertumbuhan. Bahan-bahan ini mungkin mempunyai kesan yang bererti ke 
atas pertumbuhan sel-sel epitelium mammari dan metabolisma estrogen di dalam 
payudara dan mungkin, memainkan peranan penting dalam patofisiologi dan 
perkembangan barah payudara. Estron sulfatase bertindak sebagai reservoir yang besar 
bagi estrogen-estrogen yang aktif di dalam payudara dan ditukar kepada estron oleh 
enzim estrone sulfatase Tujuan kaj ian ini adalah untuk menilai kesan BCF ke atas 
v 
dan aktiviti estron sulfatase di dalam reseptor estrogen positif MCF-7 dan reseptor 
estrogen negatif MDA-MB-23 1 titisan sel barah payudara dan untuk menentukan berat 
molekul protin-protinl peptida-peptida di dalam BeF yang bertanggungjawab terhadap 
perencatan aktiviti estron sulfatase. 
Pertumbuhan sel-sel MCF-7 dan MDA-MB-23 1 adalah direncat secara bererti 
oleh BCF. Aktiviti estron sulfatase telah direncat secara bererti di dalam sel-sel MDA­
MB-23 1 sementara aktiviti estron sulfatase dirangsang di dalam sel MCF-7 oleh BCF. 
Aktiviti estron sulfatase secara bererti telah direncat oleh kedua-dua BCF terdialisis dan 
dialisat. 
Kehadiran perencat-perencat endogen estron sulfatase di dalam BCF adalah 
penting kerana perencat-perencat ini adalah agen-agen yang berpotensi dalam rawatan 
barah payudara bersandar hormon. Sebatian-sebatian yang hadir di dalam BCF yang 
mempunyai berat molekul lebih kurang 28 kDa mungkin bertanggungjawab dalam 
perencatan pertumbuhan dan perebakan kanser payudara. 
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CHAPTER I 
INTRODUCTION 
Breast cancer represents 30% of all cancers in women and accounts for 20% 
of deaths due to cancer (Pasqualini et al., 1995). Breast cancer is the second most 
important cancer killer in the world. It occurs most commonly in postmenopausal 
women when the ovaries have stopped producing oestrogens. 
Breast cancer, like other cancers, is a disease of abnormal growth of cells. 
The epithelial cells, which line the milk producing ducts in the breast are the cells 
that typically become cancerous and form a solid mass of epithelial cells. These 
cells undergo a controlled cycle of growth and death during each menstrual cycle. 
The growth of these cells is stimulated by the action of steroid hormones such as 
oestrogen and progesterone. Breast cancer cells may metastasise to the lymph 
nodes, bones, liver, lungs and brain. 
There are several risk factors that have been associated with increased 
incidence of breast cancer. Some, like a person's age or race, can not be changed. 
Others are linked to cancer-causing factors in the environment. Still others are 
related to personal choices such as diet. Oestrogens have been shown to play an 
important role in promoting breast cancer (American Cancer Society, ACS). 
Oestrogen is a stimulator of breast epithelial cell proliferation in normal 
breast. Most breast tumours are oestrogen dependent for growth in the early stages. 
A large proportion of breast cancer subsequently become oestrogen receptor­
negative. The mechanism of this conversion is still not completely understood. 
In antioestrogen therapy the drug occupies the oestrogen receptor sites) which leads 
to artificially low oestrogen receptor values. In hormone dependent cells the 
association of the hormone with the receptor molecule is the basic step for eliciting 
a hormone response (Pasqualini et al., 1995). In cancer cells the receptor gene can 
mutate leading to non-functioning oestrogen receptors which result in cells failing 
to respond to hormone treatment. 
In the menopausal years the main source of oestrogen production is adipose 
tissue but normal and malignant breast tissues can also produce oestrogens (Reed, 
1995). Three enzyme complexes are involved in oestrogen synthesis in peripheral 
tissues (Figure 1): 
1. The aromatase enzyme complex, which converts androstenedione, secreted 
mainly by the adrenal cortex, to the weak oestrogen, oestrone (EJ). 
2 
2. Oestradiol- 17P hydroxysteroid dehydrogenase (E2DH), which in breast cancer 
tissue acts preferentially to convert oestrone (El) to the more potent oestrogen, 
oestradiol (E2). 
3. Oestrone sulphatase (EISTS), which hydrolyses the large amounts of oestrone 
sulphate (EIS) formed from oestrone EI, back to oestrone E1. 
� 
Oestrone Sulphotransferase r1oestrone sulphatase 
r---------------� 
Androstenedione Aromatase � � 
UElOH 
Testosterone Aromatase �  
Figure 1: Enzymes involved in oestrone synthesis in normal and malignant 
breast tissues. 
Adapted from Reed M.I, Molecular Medicine Today, 1: 98-103, 1995. 
In human breast tumours, the sulphatase pathway is more important than the 
aromatase pathway, because the amount of oestrone produced from oestrone 
sulphate is 10 times higher than oestrone formed from androstenedione (Santner el 
al., 1984). Thus, it has been suggested that E1S acts as a huge reservoir for 
oestrogen formation (Purohit et ai., 1995). 
3 
Breast cysts are the most common benign lesions of the female breast. In 
the Western World 7% of women are affected. Breast cysts occur mainly between 
the ages of 35 and 50 (Dixon el aI., 1983). Breast cysts produce fluid which may 
vary in colour from yellow to green to brown. Occasionally the fluid may be 
bloody. Breast cyst fluid (BCF) is rich in sex steroids including oestrone sulphate, 
and mitogenic growth factors. BCF has been found to significantly inhibit the 
oestrone sulphatase pathway in the oestrone receptor positive human breast cancer 
cell line, MCF-7. The oestrone sulphatase pathway has been shown to be 
stimulated in the oestrone receptor negative human breast cancer cell line, MDA­
MB-231 (Erbas et al., 1996). 
AIMS 
The aims of the present study were: 
1. To confirm that BCF inhibits oestrone sulphatase activity in the MCF-7 cell 
line and stimulates oestrone sulphatase activity in the MDA-MB-231 cell line. 
2. To determine the molecular weights of the proteinsipeptides in BCF responsible 
for the inhibition of oestrone sulphatase activity in the MCF-7 cell line. 
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CHAPTER II 
LITERATURE REVIEW 
2. 1 Epidemiology of Breast Cancer 
Breast cancer is a major public health problem worldwide. Breast 
cancer comprises almost one third of all new cancer cases and 20% of cancer 
deaths in women are due to breast cancer. In 1993 in the United States 46,300 
cases of breast cancer (300 males and 46,000 females) were recorded It was 
estimated in 1997 that 181,600 new cases of breast cancer would be diagnosed 
in the United States and 44, 190 people would die from the same disease during 
the same year (Hortobagyi, 1998) In 1930 the annual death rate from breast 
cancer in the United States was low but this annual death rate has continued to 
increase significantly since 1970 amongst women (Spratt et aI., 1995). 
The highest mortality rate in the world from breast cancer was found in 
the United States and England and the lowest mortality rate was found in Japan 
and Thailand (Spratt et aI., 1995). On the other hand, the Japanese living in the 
United States have a higher mortality rate from breast cancer than the Japanese 
living in Japan. In addition, Japanese born in the United States have a higher 
mortality rate from breast cancer than Japanese immigrants 
In African and Asian countries the number of breast cancer patients is slightly 
higher in premenopausal women than in postmenopausal women. This is in contrast to 
the Western countries where only a third of patients were premenopausal women (Yip 
and Ng, 1996; Natarajan et a/., 1988; Chiedozi, 1985). 
2.1.1 Breast Cancer in Malaysia 
Among Malaysian and Singaporean women breast cancer is the leading cause of 
cancer deaths (Yip and Ng, 1996). In Peninsular Malaysia, the death rate from breast 
cancer has continued to increase significantly since 1982. Figure 2. 1 shows that the 
highest mortality was found in Chinese, followed by Malays and Indians (Yip and Ng, 
1996). 
Malay women in Malaysia and Singapore have a lower incidence of breast 
cancer compared to Chinese and Indian women. This may be related to different 
lifestyles and a host of other socio-cultural differences amongst the races (Yip and Ng, 
1996). 
A group of Malaysian scientists have obtained profiles of breast cancer patients 
seen at the Breast Clinic, Kuala Lumpur Hospital (Nair et aI. , 1995). In 1994, a total of 
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Figure 2.1: Certified deaths from breast cancer by race. 
Adapted from Yip and Ng., Singapore Med 1. , 37: 264-267. 
1990 
177 new breast cancer patients were seen; 40 patients (22.6%) were below the age of 40 
years, 44% of patients were Malay, 32% were Chinese, 21 % were Indians and 3% were 
of other ethnic groups. In 1995, a total of 169 new cases were seen at the same Hospital 
(K.L. Hospital); 21 patients (22.5%) were below the age of 40 years; 44% of the 
patients were Malays, 37% Chinese, 17% Indians and 2% belonging to other ethnic 
groups (Table 2.1) 
A series of 125 cases of breast carcinoma at Kuantan General Hospital was 
studied. Overall the mean age of women was 48 years, being slightly younger (46 
years) in Malays compared to Chinese (50 years). Only 42% of their patients presented 
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